Browse

Poster Abstracts

A022

RISK STRATIFICATION OF LATERAL NECK RECURRENCE FOR PN1A PAPILLARY THYROID CANCER BASED ON THE NUMBER OF CENTRAL METASTATIC LYMPH NODES AND PRIMARY TUMOR SIZE

Endocrine Surgery

Siyuan Xu; Hui Huang; Shaoyan Liu; Jie Liu

Department of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College


A023

NEOADJUVANT SELECTIVE RET INHIBITOR FOR MEDULLARY THYROID CANCER: A CASE SERIES

Endocrine Surgery

Kevin J Contrera, MD, MPH; Maria K Gule-Monroe, MD; Maria E Cabanillas, MD; Mimi I Hu, MD; Naifa L Busaidy, MD; Ramona Dadu, MD; Steven G Waguespack, MD; Jennifer Wang, MD; Jeffery Myers, MD, PhD; Elizabeth G Grubbs, MD; Vivek Subbiah, MD; Michelle D Williams, MD; Mark E Zafereo, MD

UT MD Anderson Cancer Center


A024

SHARED DECISION-MAKING IN THE MANAGEMENT OF INDETERMINATE THYROID NODULES

Endocrine Surgery

David Forner, MD, MSc1; Victoria Taylor, BA1; Christopher W Noel, MD2; Brooke Turner, MD1; Paul Hong, MD, MSc1; Stephanie Johnson-Obaseki, MD, MPH3; David P Goldstein, MD, MSc2; Matthew H Rigby, MD, MPH1; S. Mark Taylor, MD1; Jonathan R Trites, MD1; Martin Corsten, MD1

1Dalhousie University; 2University of Toronto; 3University of Ottawa


A025

HEALTH CARE DISPARITIES AND RATES OF MALIGNANCY AMONGST CHILDREN WITH SINGLE THYROID NODULES

Endocrine Surgery

Z. Jason Qian, MD1; Eric Pineda, BS2; Hilary Seeley, MD1; Gary Hartman, MD1; Julia Noel, MD1; Lisa A Orloff, MD1; Kara D Meister, MD1

1Stanford University; 2Tulane University


A026

COMPARISON OF RISK FACTORS AND POSTOPERATIVE OUTCOMES IN PRIMARY AND SECONDARY/TERTIARY HYPERPARATHYROIDISM

Endocrine Surgery

Ryan M Kong, BS; Jennifer Liang, MD; Natalya Chernichenko, MD

SUNY Downstate Health Sciences University


A027

FACTORS ASSOCIATED WITH REFUSAL OF SURGERY IN DIFFERENTIATED THYROID CARCINOMA

Endocrine Surgery

Aman Prasad, BS1; Ryan M Carey, MD2; Robert M Brody, MD2; Steven B Cannady, MD2; Jason G Newman, MD2; Jason Brant, MD2; Karthik Rajasekaran, MD2

1Perelman School of Medicine at the University of Pennsylvania; 2Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine


A029

IMPLICATIONS OF EMERGENCY DEPARTMENT PRESENTATION FOR HEAD AND NECK CANCER SURGERY

Functional Outcomes / Quality

James A Gallogly, MD; Jennifer V Brinkmeier, MD; Sean T Massa, MD, MSCI

Saint Louis University School of Medicine


A030

ASSESSING THE NUTRITIONAL RISK INDEX AS A PREDICTOR OF POSTOPERATIVE COMPLICATIONS IN HEAD AND NECK CANCER SURGERY

Functional Outcomes / Quality

Rushi Patel, BA; Vraj P Shah, BS; Prayag Patel, MD; Jean A Eloy, MD, FACS, FARS

Rutgers New Jersey Medical School


A031

OPIOID PRESCRIBING PATTERNS ACROSS HEAD AND NECK CANCER ONCOLOGY TEAMS AND OTOLARYNGOLOGY PROVIDERS

Functional Outcomes / Quality

Neelam Phalke, MD1; Christine Settoon, MD1; Michael Olejniczak, MD2; John N Poche, MD1; Delaney Sheehan, MD3; Lee McDaniel, PhD4; Ashley C Mays, MD1

1Louisiana State University Otolaryngology; 2Louisiana State University General Surgery; 3University of Alabama Otolaryngology; 4Louisiana State University Department of Public Health


A032

APPLICATION OF FIBRIN SEALANT TO THE TRANSORAL SURGICAL DEFECT SIGNIFICANTLY REDUCES OPIOID USE AND POSTOPERATIVE PAIN

Functional Outcomes / Quality

Samantha M Cleveland, MD1; Stacey L Tannenbaum, PhD2; Crista Horton, MD2; Ryan H Sobel, MD3

1Department of Surgery, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A; 2Broward Health Research Institute, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A; 3Division of Head & Neck Surgery and Oncology, Department of Surgery, Broward Health Medical Center, Fort Lauderdale, Florida, U.S.A